Hoekstra, J., &Sauter, W.(2018). What Standard for Excessive Pricing in EU law? A Discussion of the Competition Appeal Tribunal’s Judgment in the Pfizer/Flynn v CMA Case. European Pharmaceutical Law Review, 2(4). Retrieved from https://doi.org/10.21552/eplr/2018/4/9